760 related articles for article (PubMed ID: 24939945)
21. Correlation Between Quantitative Uptake of
Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L
Front Cardiovasc Med; 2021; 8():663929. PubMed ID: 34722650
[No Abstract] [Full Text] [Related]
22. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
24. Spleen visualization in both TTR and AL amyloidosis during
Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
[TBL] [Abstract][Full Text] [Related]
25. Quantitative SPECT/CT parameters of myocardial
Ben-Haim S; Chicheportiche A; Goshen E; Arad M; Smekhov M; Menezes LJ; Elliott PM; O'Mahoney E; Stern E; Yuzefovich B; Bomanji JB
EJNMMI Res; 2021 Sep; 11(1):86. PubMed ID: 34487268
[TBL] [Abstract][Full Text] [Related]
26. Cardiac transthyretin amyloidosis
Löfbacka V; Axelsson J; Pilebro B; Suhr OB; Lindqvist P; Sundström T
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1822-1832. PubMed ID: 33367948
[TBL] [Abstract][Full Text] [Related]
27.
Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
[TBL] [Abstract][Full Text] [Related]
28. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis.
Stats MA; Stone JR
Cardiovasc Pathol; 2016; 25(5):413-7. PubMed ID: 27469499
[TBL] [Abstract][Full Text] [Related]
29. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
[TBL] [Abstract][Full Text] [Related]
30. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration.
Rudolphi Solero T; Feriche Aragón M; Amrani Raissouni T; Delgado-García A; Cañada-Rodríguez MJ; Sanz Viedma S
Clin Nucl Med; 2024 Feb; 49(2):e65-e67. PubMed ID: 38048549
[TBL] [Abstract][Full Text] [Related]
31. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.
Puille M; Altland K; Linke RP; Steen-Müller MK; Kiett R; Steiner D; Bauer R
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):376-9. PubMed ID: 12002714
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis.
Takahashi K; Hiratsuka Y; Iwamura T; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Morioka H; Okura T; Enomoto D; Uemura S; Kono T; Sakaue T; Ikeda S
Amyloid; 2024 Mar; 31(1):12-21. PubMed ID: 37486102
[TBL] [Abstract][Full Text] [Related]
33. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis.
Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Cunha N; Rodrigues T; Santos L; Conceição I; Agostinho J; Pinto FJ
Amyloid; 2024 Mar; 31(1):32-41. PubMed ID: 37493395
[TBL] [Abstract][Full Text] [Related]
35. Molecular imaging of amyloidosis: will the heart be the next target after the brain?
Chen W; Dilsizian V
Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845
[TBL] [Abstract][Full Text] [Related]
36. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
[TBL] [Abstract][Full Text] [Related]
37.
Flaherty KR; Morgenstern R; Pozniakoff T; DeLuca A; Castano A; Maurer MS; Bokhari S
J Nucl Cardiol; 2020 Apr; 27(2):371-380. PubMed ID: 31463816
[TBL] [Abstract][Full Text] [Related]
38. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
39. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
[TBL] [Abstract][Full Text] [Related]
40.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
